Thromboembolism

News

August 15, 2019

2 min read

Save

SENSE: Single-lead system performs similarly to dual-chamber ICDs

A novel implantable cardioverter defibrillator system without an atrial lead was similar to dual-chamber ICDs and superior to single-chamber ICDs at detecting atrial high-rate episodes, according to the results of the SENSE trial.

News

August 12, 2019

1 min read

Save

Venous thromboembolism risk factors common among postpartum women

Venous thromboembolism risk factors appeared highly prevalent among postpartum women at a Dublin hospital, according to results of a cross-sectional study published in Journal of Thrombosis and Haemostasis.

Part of the Healio Network

Left Ventricular Non-Compaction

Left ventricular non-compaction, also known as LVNC, spongy myocardium or hypertrabeculation syndrome, is a pathologic cardiac condition in which the myocytes exhibit a “spongy” appearance.

Part of the Healio Network

Rivaroxaban

Rivaroxaban (Xarelto, Janssen/Bayer) is a direct factor Xa inhibitor used orally in the prevention of thromboembolism in the setting of atrial fibrillation or atrial flutter.

Part of the Healio Network

Non-Compaction (Left Ventricular)

Left ventricular non-compaction (a.k.a. LVNC, spongy myocardium or hypertrabeculation syndrome) is a pathologic cardiac condition in which the myocytes exhibit a “spongy” appearance.